Laurence D. Fink is the Chairman and CEO of BlackRock, a global leader in investment and technology solutions, founded in 1988. Under his leadership, BlackRock has become the world's largest investment management firm, focused on helping clients build better financial futures through innovative solutions and trusted expertise. His expertise in identifying promising opportunities in the intersection of technology and life sciences has led to strategic investments in companies like Exscientia, which utilize AI to revolutionize drug development. With a focus on driving innovation and transformative advancements in healthcare, Larry Fink's leadership at BlackRock contributes to shaping the future of AI-driven drug discovery and its potential to revolutionize the pharmaceutical industry.